These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12019347)

  • 21. Effects of melatonin in two individuals with Alzheimer's disease.
    Jean-Louis G; Zizi F; von Gizycki H; Taub H
    Percept Mot Skills; 1998 Aug; 87(1):331-9. PubMed ID: 9760668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A chronobiological approach in treatment of sleep disturbances in Alzheimer's dementia patients].
    Doljansky JT; Dagan Y
    Harefuah; 2006 Jun; 145(6):437-40, 470. PubMed ID: 16838900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tackling sundowning in a patient with Alzheimer's disease.
    Sharer J
    Medsurg Nurs; 2008 Feb; 17(1):27-9. PubMed ID: 18429537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep in Alzheimer's disease and the sundown syndrome.
    Vitiello MV; Bliwise DL; Prinz PN
    Neurology; 1992 Jul; 42(7 Suppl 6):83-93; discussion 93-4. PubMed ID: 1630644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of daytime napping and Parkinsonian signs in Alzheimer's disease.
    Park M; Comella CL; Leurgans SE; Fan W; Wilson RS; Bennett DA
    Sleep Med; 2006 Dec; 7(8):614-8. PubMed ID: 17023213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women.
    Pawlikowski M; Kolomecka M; Wojtczak A; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():17-9. PubMed ID: 12019346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin and Sleep Disturbances in Alzheimer's Disease.
    Prodhan AHMSU; Cavestro C; Kamal MA; Islam MA
    CNS Neurol Disord Drug Targets; 2021; 20(8):736-754. PubMed ID: 34348635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review.
    de Jonghe A; Korevaar JC; van Munster BC; de Rooij SE
    Int J Geriatr Psychiatry; 2010 Dec; 25(12):1201-8. PubMed ID: 21086534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients.
    Sinforiani E; Terzaghi M; Pasotti C; Zucchella C; Zambrelli E; Manni R
    Neurol Sci; 2007 Apr; 28(2):96-9. PubMed ID: 17464473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial.
    Peles E; Hetzroni T; Bar-Hamburger R; Adelson M; Schreiber S
    Addiction; 2007 Dec; 102(12):1947-53. PubMed ID: 17916225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep in schizophrenia: impairments, correlates, and treatment.
    Benson KL
    Psychiatr Clin North Am; 2006 Dec; 29(4):1033-45; abstract ix-x. PubMed ID: 17118280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin: media hype or therapeutic breakthrough?
    Kendler BS
    Nurse Pract; 1997 Feb; 22(2):66-7, 71-2, 77. PubMed ID: 9055317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Delayed wakefulness-sleep rhythm syndrome and melatonin. Synthesis of existing studies].
    Quera Salva MA; Lainey E; Léger D; Santos C; Billiard M
    Rev Neurol (Paris); 2001 Nov; 157(11 Pt 2):S126-9. PubMed ID: 11924024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects.
    Valtonen M; Niskanen L; Kangas AP; Koskinen T
    Nord J Psychiatry; 2005; 59(3):217-21. PubMed ID: 16195124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of sleep and nighttime disturbances in Alzheimer's disease: a behavior management approach.
    McCurry SM; Logsdon RG; Vitiello MV; Teri L
    Sleep Med; 2004 Jul; 5(4):373-7. PubMed ID: 15222994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohort.
    Gillette-Guyonnet S; Cortes F; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):69-73. PubMed ID: 15791348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Working under daylight intensity lamp: an occupational risk for developing circadian rhythm sleep disorder?
    Doljansky JT; Kannety H; Dagan Y
    Chronobiol Int; 2005; 22(3):597-605. PubMed ID: 16076658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.